188 related articles for article (PubMed ID: 35763353)
21. Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types.
Malta-Vacas J; Aires C; Costa P; Conde AR; Ramos S; Martins AP; Monteiro C; Brito M
J Clin Pathol; 2005 Jun; 58(6):621-5. PubMed ID: 15917414
[TBL] [Abstract][Full Text] [Related]
22. p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates.
Nguyen TV; Li J; Lu CJ; Mamrosh JL; Lu G; Cathers BE; Deshaies RJ
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3565-3571. PubMed ID: 28320958
[TBL] [Abstract][Full Text] [Related]
23. SJPYT-195: A Designed Nuclear Receptor Degrader That Functions as a Molecular Glue Degrader of GSPT1.
Huber AD; Li Y; Lin W; Galbraith AN; Mishra A; Porter SN; Wu J; Florke Gee RR; Zhuang W; Pruett-Miller SM; Peng J; Chen T
ACS Med Chem Lett; 2022 Aug; 13(8):1311-1320. PubMed ID: 35978691
[TBL] [Abstract][Full Text] [Related]
24. The role of miR-144/GSPT1 axis in gastric cancer.
Tian QG; Tian RC; Liu Y; Niu AY; Zhang J; Gao WF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4138-4145. PubMed ID: 30024602
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies against human translation termination factor eRF3 and their utilization for sub-cellular localization of eRF3.
Delage MM; Dutertre S; Le Guével R; Frolova L; Berkova N
J Biochem; 2011 Jul; 150(1):49-59. PubMed ID: 21421683
[TBL] [Abstract][Full Text] [Related]
26. Vimentin binds to a novel tumor suppressor protein, GSPT1-238aa, encoded by circGSPT1 with a selective encoding priority to halt autophagy in gastric carcinoma.
Hu F; Peng Y; Chang S; Luo X; Yuan Y; Zhu X; Xu Y; Du K; Chen Y; Deng S; Yu F; Feng X; Fan X; Ashktorab H; Smoot D; Meltzer SJ; Li S; Wei Y; Zhang X; Jin Z
Cancer Lett; 2022 Oct; 545():215826. PubMed ID: 35839920
[TBL] [Abstract][Full Text] [Related]
27. Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1.
Hoshino S; Imai M; Mizutani M; Kikuchi Y; Hanaoka F; Ui M; Katada T
J Biol Chem; 1998 Aug; 273(35):22254-9. PubMed ID: 9712840
[TBL] [Abstract][Full Text] [Related]
28. Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders.
Yang J; Li Y; Aguilar A; Liu Z; Yang CY; Wang S
J Med Chem; 2019 Nov; 62(21):9471-9487. PubMed ID: 31560543
[TBL] [Abstract][Full Text] [Related]
29. eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development.
Malta-Vacas J; Chauvin C; Gonçalves L; Nazaré A; Carvalho C; Monteiro C; Bagrel D; Jean-Jean O; Brito M
Oncol Rep; 2009 Jun; 21(6):1551-8. PubMed ID: 19424636
[TBL] [Abstract][Full Text] [Related]
30. [Recent topics in IMiDs and cereblon].
Ito T; Handa H
Rinsho Ketsueki; 2017; 58(10):2067-2073. PubMed ID: 28978850
[TBL] [Abstract][Full Text] [Related]
31. G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1.
Lee JA; Park JE; Lee DH; Park SG; Myung PK; Park BC; Cho S
Oncogene; 2008 Feb; 27(9):1297-305. PubMed ID: 17700517
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
Zhang C; Zou Y; Dai DQ
Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
[TBL] [Abstract][Full Text] [Related]
33. The E3 ligase TRIM31 regulates hematopoietic stem cell homeostasis and MLL-AF9 leukemia.
Zhang K; Liu D; Li Y; Shi Z; Guo J; Gao C; Wang H; Ju Z; Diao D
Haematologica; 2023 Aug; 108(8):2116-2129. PubMed ID: 36632737
[TBL] [Abstract][Full Text] [Related]
34. Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation.
Norris S; Ba X; Rhodes J; Huang D; Khambatta G; Buenviaje J; Nayak S; Meiring J; Reiss S; Xu S; Shi L; Whitefield B; Alexander M; Horn EJ; Correa M; Tehrani L; Hansen JD; Papa P; Mortensen DS
J Med Chem; 2023 Dec; 66(23):16388-16409. PubMed ID: 37991844
[TBL] [Abstract][Full Text] [Related]
35. GSPT1 Functions as a Tumor Promoter in Human Liver Cancer.
Xi YQ; Gao JB; Li XF; Xu LH; Li Z; Yang LJ; Wang J; Wang HQ; Fang XC; Huang SR; Xie W; Feng MH; Zhang JW
Curr Med Sci; 2023 Feb; 43(1):104-114. PubMed ID: 36459303
[TBL] [Abstract][Full Text] [Related]
36. miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1.
Xiao R; Li C; Chai B
Biomed Pharmacother; 2015 Aug; 74():138-44. PubMed ID: 26349975
[TBL] [Abstract][Full Text] [Related]
37. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia.
Brennan L; Narendran A
Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487
[TBL] [Abstract][Full Text] [Related]
38. Long Non-coding RNA MINCR Regulates miR-876-5p/GSPT1 Axis to Aggravate Glioma Progression.
Li Z; Xie X; Fan X; Li X
Neurochem Res; 2020 Jul; 45(7):1690-1699. PubMed ID: 32333234
[TBL] [Abstract][Full Text] [Related]
39. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
40. Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries.
Wang B; Liu J; Tandon I; Wu S; Teng P; Liao J; Tang W
Eur J Med Chem; 2021 Jul; 219():113425. PubMed ID: 33862513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
